|
⚲
|
| Keyboard |
| Mark Corrigan | |
|---|---|
| Firm | |
| Address | 1035 Cambridge Street Suite 17B Cambridge, MA 02141 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Exacis Biotherapeutics Inc | 021-388374 | Director | 0.1 M of 3.0 M |
||
| Exacis Biotherapeutics Inc | 021-388357 | Director | 1.1 M of 3.0 M |
||
| Perseus Holdings USA LLC | 021-385455 | Director | 2.1 M | ||
| Nabriva Therapeutics PLC | 021-317965 | Director | 21.3 M of 26.9 M |
||
| Tremeau Pharmaceuticals Inc | 021-305704 | Executive Officer | 5.2 M of 5.2 M |
||
| Synereca Pharmaceuticals Inc | 021-292834 | Director | 0.6 M of 1.2 M |
||
| Zalicus Inc | 021-152398 | Executive Officer | |||